Form 8-K Tonix Pharmaceuticals For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
Tonix Pharmaceuticals (TNXP) Misses Q3 EPS by 2c
November 10, 2014 9:20 AM ESTTonix Pharmaceuticals (NASDAQ: TNXP) reported Q3 EPS of ($0.71), $0.02 worse than the analyst estimate of ($0.69).
For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.
... More